Latest filing published 08 Jul 2026 for Puma Biotechnology, INC., €61k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Douglas M. Hunt appears in our data through filings on Puma Biotechnology, Inc. shares, published by SEC (Form 4). The record holds 34 filings, for trades running from 3 May 2021 to 6 July 2026.
On the market, this insider has only sold: 29 sales, €277k in total. Other entries cover 5 share grants. In 2026 alone, the filings show no purchases and 2 sales.
On 8 July 2026 came the latest disclosure, an open-market sale for €61k in Puma Biotechnology, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 34 declarations